TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in BOLD activation in Nucleus accumbens/Ventral striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saint Louis University Mental Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of diagnostic confidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of major n-grade revisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of major n-grade revisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of all n-grade revisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of all n-grade revisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of incidence of AEs, TEAE, SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Number of incidence of clinical laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in forced vital capacity (FVC) [% predicted]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in dyspnoea symptom score [points]
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in cough symptom score [points]
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in BOLD response in the cerebellum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in BOLD response in the ventral striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in food reward valuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ad libitum snack food intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in % with HbA1c <7.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Hyperglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Hypoglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-emergent clinically significant changes in clinical laboratory safety tests
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-emergent clinically significant changes in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Gastric volume (ml/kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Responder Status of at least 50% Reduction in the Frequency of Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Closure in Diabetic Foot Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving iPGA Score of Clear or Almost Clear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Analyte Concentration (Cmax) of Macitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Analyte Concentration Versus Time Curve (AUC [0-last]) of Macitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Analyte Concentration-time Curve (AUC[0-infinity]) of Macitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of suspected unexpected serious adverse reactions (SUSAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Activities-specific Balance Confidence scale-16 items (ABC-16)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Longitudinal strain peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Voltage of the left atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The global perceived improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Burden at three months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Burden at six months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absence of pathological mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of soft tissue pathologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of pain on percussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral mucositis evaluation according to WHO scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral mucositis evaluation according to NCI scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral mucositis evaluation according to CHIMES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensive care length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence and types of dose limited toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate (cure plus improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUC0-inf) of Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Smoking ≥ 10 Cigarettes/Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obesity-specific personal efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-operative quality of life at D30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline in modified Unified Multiple System Atrophy Rating Scale (mUMSARS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline in Unified Multiple System Atrophy Rating Scale (UMSARS) Total Score (TS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of recurrence of abnormal uterine blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Positive Aspects of Caregiving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Fridericia Heart Rate Corrected QT Interval (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful cardioversion of PSVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grams of red meat consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Adherence to blood pressure monitoring recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pain medication consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neuroactive Steroid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in inflammatory markers c reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammatory markers interleukin 6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammatory markers tumor necrosis factor (TNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammatory markers (leptin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in inflammatory markers (adiponectin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative shoulder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain
Endpoint domain: Adverse events/effects
Primary endpoint: Wisconsin Stone Quality of Life questionnaire (WISQOL) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospitalisation for CV reason
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to next pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Fracture of Material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of Material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to use personal health information technology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of complication
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in blood pressure over 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in quality of life indicators over 8 weeks
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in basal cardiac function and stress reactivity at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain intensity measured by vNRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle mass of the quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bioavailability of melatonin (AUC 0-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic posturography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline scores using the Epilepsy Anxiety Survey Instrument (EASI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in baseline scores using the Perceived Stress Scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in RV/LV diameter ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidences of anomalies
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of moderate calcification artery calcium (CAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in time-in-target-range (3.9-10 mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence or absence of coronary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum level of insulin-like growth factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of occurrences of a MAP
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration versus time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Peak Plasma Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression in cognition function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: measurement of tissue stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement of passive muscle tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement of the range of shoulder joint motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-related symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: apnea - hypopnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Epworth Daytime Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pain subscale - Knee Injury and Osteoarthritis Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Activities of daily living subscale - Knee Injury and Osteoarthritis Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Independent objective reviewer scoring of matched photographs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with change from baseline in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and magnitude of treatment emergent clinical laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell fractions from blood, tumor, and MPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: real-world overall survival (rwOS) during 12 months from index date
Endpoint domain: Mortality/survival
Primary endpoint: real-world progression-free survival (rwPFS) during 12 months from index date
Endpoint domain: Mortality/survival
Primary endpoint: real-world intracranial overall response rate (rwICORR) at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of EBLSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerable dose (MTD)/ Recommended Phase II Dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain on the Neonatal Infant Pain Scale (NIPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of all cause death patients in 30 days following TAVI
Endpoint domain: Mortality/survival
Primary endpoint: Sustained response to aerSleep II therapy at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of nivolumab-related immune-related adverse events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of nivolumab-related immune-related adverse events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of nivolumab-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: blood glucose level monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: safety of SGLT2 inhibitors usage during ramadan
Endpoint domain: Adverse events/effects
Primary endpoint: Academic Achievement Test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood and chemical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score of psychophysiological reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embodiment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in AMH Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: VO2 kinetic response to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Function (Stroop test)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive Function (decision reaction test)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Day-time continence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Night-time continence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline M1 / P1 angle at day 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of zctas with >15% population HIV tested
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of SLD on sepsis outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Step length (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step time (sec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinically Significant Changes in Blood Laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with Clinically Significant Changes in Urine Laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Endoscopic ultrasound fine needle biopsy sample quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy according to histological analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of recovery from cold and flu-like symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of transcranial alternating current stimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability of transcranial alternating current stimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects with good clinical outcome defined as Modified Rankin Score (mRS) of ≤2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device-related or procedure-related symptomatic intracranial hemorrhage (sICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom-relieving medication use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain self efficacy questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in the Child Behaviour Checklist (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in the Life Events Checklist (LEC)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in Child Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Indicators of insulin sensitivity and carbohydrate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Indicators of lipid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Indicators of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Asthenia measured by MFI-20
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of exercises remembered
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of exercises done correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in EDC metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) of Brensocatib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short- and long-term prognosis of patients
Endpoint domain: Mortality/survival
Primary endpoint: Variation in glycated hemoglobin (HbA1c) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of measurement methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of measurement methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central nervous system Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Short Form McGill Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analysis of Inflammatory Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fall Risk Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Test of Sensory Integration and Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall safety from unanticipated problems or risks
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness and overall change in reported primary symptom of concern: Chronic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness and overall change in reported primary symptom of concern: Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness and overall change in reported primary symptom of concern: Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness and overall change in reported primary symptom of concern: Sleeplessness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Kinematic change of the upper limb during ADLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of activities of daily living(ADL) tasks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle activation change of the upper limb during ADLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Spastic Paraplegia Rating Scale (SPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Students' total scores in sequential cardiology long case examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life Scale Level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life